Clerodane Furanoditerpenoids from Tinospora bakis (A.Rich.) Miers (Menispermaceae)
Molecules · 2023
DOI: 10.3390/molecules29010154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Ahmed Saeed Kabbashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan. Hauptthemen laut MEDLINE: Tinospora, Menispermaceae, Diterpenes, Clerodane, Coleoptera. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Administration of Traditional Chinese Medicine, Higher Education Commission, Sindh Higher Education Commission.
Abstract (Originalsprache)
Tinospora bakis (A.Rich.) Miers (Menispermaceae) has traditionally been used to alleviate headaches, rheumatism, mycetoma, and diabetes, among others. Despite its extensive use, the active components of the plant have never been investigated. In this work, a series of furanoditerpenoids (1–18) and five compounds from other classes (19–23) were isolated from T. bakis. Notably, two new compounds were discovered and named: tinobakisin (1) and tinobakiside (10). Their molecular structures were elucidated with NMR, MS, UV, IR, and ECD spectra. Additionally, known compounds (2–9 and 11–23) were corroboratively identified through spectral comparisons with previously reported data, while highlighting and addressing some inaccuracies in the prior literature. Remarkably, compounds 6, 7, 13, and 17 exhibited a superior anti-glycation effect, outperforming established agents like rutin and quercetin in a lab model of protein glycation with glucose. The overall findings suggest that furanoditerpenoids play a crucial role in the antidiabetic properties of T. bakis. This research marks the first comprehensive phytochemical investigation of T. bakis, opening the door for further investigation into furanoditerpenoids and their biological mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.
- Department of Microbiology, Faculty of Pure and Applied Sciences, International University of Africa, Khartoum 12223, Sudan.
- Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.
- Third World Center (TWC) for Chemical Sciences, International Center for Chemical & Biological Sciences, University of Karachi, Karachi 75270, Pakistan.
ORCID-Profile: Humera Jahan, Farooq-Ahmad Khan
Förderung
- National Administration of Traditional Chinese Medicine
- Higher Education Commission
- Sindh Higher Education Commission
- The World Academy of Science
- Higher Education Commission of Pakistan
- Medicinal and Aromatic Plants and Traditional Medicine Research Institute (MAPTMRI)
- Faculty of Pure and Applied Sciences, International University of Africa, Khartoum, Sudan
Zitieren
APA
Kabbashi, A. S., Sattar, M. A., Aamer, M., Siddiqui, N. N., Kamran, M., Fayaz, A., Jahan, H., Khan, F. A., & Wang, Y. (2023). Clerodane Furanoditerpenoids from Tinospora bakis (A.Rich.) Miers (Menispermaceae). Molecules. https://doi.org/10.3390/molecules29010154
Vancouver
Kabbashi AS, Sattar MA, Aamer M, Siddiqui NN, Kamran M, Fayaz A, et al. Clerodane Furanoditerpenoids from Tinospora bakis (A.Rich.) Miers (Menispermaceae). Molecules. 2023. doi:10.3390/molecules29010154
BibTeX
@article{Kabbashi2023,
author = {Kabbashi, Ahmed Saeed and Sattar, Maazah Abdul and Aamer, Muhammad and Siddiqui, Nimra Naz and Kamran, Muhammad and Fayaz, Aneela and Jahan, Humera and Khan, Farooq-Ahmad and Wang, Yan},
title = {Clerodane Furanoditerpenoids from Tinospora bakis (A.Rich.) Miers (Menispermaceae)},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules29010154}
}
EUVIMED